Prelude Capital Management’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-14,744
| Closed | -$1.68M | – | 1037 |
|
|
2025
Q1 | $1.68M | Buy |
+14,744
| New | +$1.68M | 0.13% | 154 |
|
|
2020
Q3 | – | Sell |
-5,978
| Closed | -$101K | – | 1449 |
|
|
2020
Q2 | $101K | Buy |
5,978
+2,059
| +53% | +$34.8K | 0.01% | 662 |
|
|
2020
Q1 | $47K | Sell |
3,919
-5,964
| -60% | -$71.5K | ﹤0.01% | 490 |
|
|
2019
Q4 | $120K | Buy |
+9,883
| New | +$120K | ﹤0.01% | 679 |
|
|
2019
Q3 | – | Sell |
-4,100
| Closed | -$46K | – | 1248 |
|
|
2019
Q2 | $46K | Buy |
4,100
+2,500
| +156% | +$28K | ﹤0.01% | 799 |
|
|
2019
Q1 | $19K | Sell |
1,600
-75,906
| -98% | -$901K | ﹤0.01% | 954 |
|
|
2018
Q4 | $1.04M | Buy |
77,506
+20,737
| +37% | +$277K | 0.07% | 187 |
|
|
2018
Q3 | $796K | Sell |
56,769
-1,000
| -2% | -$14K | 0.05% | 265 |
|
|
2018
Q2 | $908K | Buy |
57,769
+1,000
| +2% | +$15.7K | 0.06% | 261 |
|
|
2018
Q1 | $934K | Buy |
56,769
+4,968
| +10% | +$81.7K | 0.07% | 249 |
|
|
2017
Q4 | $936K | Buy |
51,801
+19,452
| +60% | +$351K | 0.08% | 226 |
|
|
2017
Q3 | $624K | Buy |
32,349
+19,020
| +143% | +$367K | 0.06% | 286 |
|
|
2017
Q2 | $157K | Sell |
13,329
-4,200
| -24% | -$49.5K | 0.01% | 586 |
|
|
2017
Q1 | $192K | Sell |
17,529
-19,900
| -53% | -$218K | 0.02% | 534 |
|
|
2016
Q4 | $272K | Buy |
+37,429
| New | +$272K | 0.03% | 436 |
|
|
2016
Q1 | – | Sell |
-11,900
| Closed | -$59K | – | 1219 |
|
|
2015
Q4 | $59K | Hold |
11,900
| – | – | 0.01% | 945 |
|
|
2015
Q3 | $45K | Buy |
+11,900
| New | +$45K | 0.01% | 1011 |
|